Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Johnson Matthey Plc (JMAT.L)
London, GB
Johnson Matthey Plc is a global enterprise specializing in sustainable technologies, particularly in clean air solutions, advanced catalysts, hydrogen technology, and services related to platinum group metals (PGMs). Its extensive operations span the UK, Germany, broader Europe, North America, various parts of Asia (including China and Hong Kong), and other international markets. The company organizes its diverse activities into three primary divisions: Clean Air, Efficient Natural Resources, and Other Markets. The Clean Air division is dedicated to manufacturing catalysts essential for emission control after-treatment systems. These products play a crucial role in reducing noxious emissions from a wide array of diesel and gasoline-powered vehicles, including cars, light commercial vehicles, heavy-duty trucks, buses, and off-road machinery. Within the Efficient Natural Resources segment, Johnson Matthey offers a comprehensive suite of products and processing services designed to optimize the utilization and transformation of vital natural resources such as oil, natural gas, biomass, and platinum group metals. This segment is also a leader in circular economy initiatives, providing specialized catalysts and additives, licensing advanced process technologies and engineering designs, and delivering essential refining, recycling, and other services for platinum group and precious metals, alongside various chemical and industrial products. The Other Markets segment encompasses a diverse portfolio, featuring precious metal pastes and enamels, advanced battery systems, cutting-edge fuel cell technologies, high-performance battery materials, and pioneering green hydrogen solutions. Additionally, this segment leverages scientific and technological expertise to develop products for medical devices and provides sophisticated detection, diagnostic, and measurement offerings. Tracing its origins back to 1817, the company, originally named Johnson & Cock, adopted its current designation, Johnson Matthey Plc, in 1851. Its corporate headquarters remain situated in London, United Kingdom.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.18% | +0.74% | +7.52% | +8.05% | +9.25% | +1.97% | +27.13% | +24.83% | -28.63% | -24.62% | +279.41% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 5 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+7.7% ★ Q1'26: +14.4% (vs Q1'24)
-
EPS growth Chemicals - Specialty: +13.2%-127.0% Q1'26: -291.7% (vs Q1'24)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+0.7% Q1'26: +2.1% (vs Q1'24)
-
EBIT margin Chemicals - Specialty: +8.8%+2.6% Q1'26: +2.2% (vs Q1'24)
-
ROIC Chemicals - Specialty: +5.6%+7.0% ★ Q1'26: +13.5% (vs Q1'24)
-
Share dilution Chemicals - Specialty: +0.1%-4.7% ★ Q1'26: -8.8% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.93× Q1'26: 1.51× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2010 actual |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 5 Rev. Ana. 6 EPS Ana. |
Mar 2027 5 Rev. Ana. 6 EPS Ana. |
Mar 2028 4 Rev. Ana. 5 EPS Ana. |
Mar 2029 2 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
7.84B
est: 7.63B (+2.8%)
|
9.98B
est: 10.40B (-4.0%)
|
12.02B
est: 11.30B (+6.4%)
|
10.73B
est: 10.94B (-1.9%)
|
10.06B
est: 3.08B (+226.5%)
|
10.72B
est: 3.19B (+235.6%)
|
12.04B
est: 3.50B (+244.1%)
|
10.27B
est: 3.85B (+166.9%)
|
10.75B
est: 4.18B (+156.8%)
|
14.58B
est: 4.20B (+247.3%)
|
15.44B
est: 3.88B (+297.8%)
|
16.03B
est: 4.05B (+296.2%)
|
14.93B
est: 4.03B (+270.5%)
|
12.84B
est: 4.11B (+212.2%)
|
11.67B
est: 3.40B (+243.2%)
|
2.91B
2.52B – 3.23B
-14.6% YoY
|
2.61B
2.48B – 2.74B
-10.2% YoY
|
2.56B
2.55B – 2.58B
-1.8% YoY
|
2.53B
2.48B – 2.57B
-1.4% YoY
|
2.69B
2.56B – 2.82B
+6.3% YoY
|
| EBITDA |
379.30M
est: 399.99M (-5.2%)
|
460.60M
est: 458.98M (+0.4%)
|
591.10M
est: 442.12M (+33.7%)
|
539.30M
est: 503.76M (+7.1%)
|
695.60M
est: 182.58M (+281.0%)
|
598.00M
est: 507.80M (+17.8%)
|
652.00M
est: 680.76M (-4.2%)
|
625.00M
est: 673.48M (-7.2%)
|
765.00M
est: 570.27M (+34.1%)
|
673.00M
est: 609.48M (+10.4%)
|
544.00M
est: 358.45M (+51.8%)
|
454.00M
est: 367.96M (+23.4%)
|
621.00M
est: 394.64M (+57.4%)
|
488.00M
est: 419.19M (+16.4%)
|
802.00M
est: 144.56M (+454.8%)
|
123.15M
106.73M – 136.77M
-14.8% YoY
|
110.61M
105.22M – 115.99M
-10.2% YoY
|
108.66M
108.05M – 109.26M
-1.8% YoY
|
107.12M
105.22M – 109.01M
-1.4% YoY
|
113.81M
108.27M – 119.35M
+6.2% YoY
|
| EBIT |
258.50M
est: 338.06M (-23.5%)
|
291.80M
est: 327.94M (-11.0%)
|
444.30M
est: 304.31M (+46.0%)
|
389.70M
est: 409.40M (-4.8%)
|
542.40M
est: 148.38M (+265.5%)
|
426.20M
est: 435.67M (-2.2%)
|
493.00M
est: 460.02M (+7.2%)
|
380.00M
est: 545.42M (-30.3%)
|
594.00M
est: 388.47M (+52.9%)
|
495.00M
est: 532.29M (-7.0%)
|
374.00M
est: 349.44M (+7.0%)
|
277.00M
est: 358.72M (-22.8%)
|
434.00M
est: 384.72M (+12.8%)
|
296.00M
est: 408.66M (-27.6%)
|
615.00M
est: 99.83M (+516.0%)
|
85.04M
73.71M – 94.45M
-14.8% YoY
|
76.39M
72.67M – 80.10M
-10.2% YoY
|
75.04M
74.62M – 75.45M
-1.8% YoY
|
73.97M
72.66M – 75.28M
-1.4% YoY
|
78.60M
74.77M – 82.42M
+6.3% YoY
|
| Net Income |
164.20M
est: 210.08M (-21.8%)
|
181.50M
est: 214.27M (-15.3%)
|
315.90M
est: 197.80M (+59.7%)
|
271.80M
est: 298.78M (-9.0%)
|
428.70M
est: 108.29M (+295.9%)
|
333.10M
est: 350.55M (-5.0%)
|
386.00M
est: 365.80M (+5.5%)
|
298.00M
est: 426.87M (-30.2%)
|
413.00M
est: 322.46M (+28.1%)
|
255.00M
est: 414.00M (-38.4%)
|
205.00M
est: 229.66M (-10.7%)
|
-101.00M
est: 235.76M (-142.8%)
|
276.00M
est: 264.00M (+4.5%)
|
108.00M
est: 108.00M (+0.0%)
|
373.00M
est: 239.82M (+55.5%)
|
235.09M
210.35M – 259.83M
-2.0% YoY
|
277.35M
247.92M – 306.79M
+18.0% YoY
|
346.39M
279.07M – 413.70M
+24.9% YoY
|
403.95M
378.38M – 429.51M
+16.6% YoY
|
428.69M
401.56M – 455.82M
+6.1% YoY
|
| SGA |
103.50M
est: 270.45M (-61.7%)
|
112.10M
est: 316.18M (-64.5%)
|
302.90M
est: 305.40M (-0.8%)
|
288.20M
est: 286.49M (+0.6%)
|
340.60M
est: 103.83M (+228.0%)
|
316.00M
est: 275.89M (+14.5%)
|
349.00M
est: 347.02M (+0.6%)
|
383.00M
est: 361.84M (+5.8%)
|
442.00M
est: 411.20M (+7.5%)
|
462.00M
est: 444.08M (+4.0%)
|
480.00M
est: 407.98M (+17.7%)
|
501.00M
est: 418.81M (+19.6%)
|
529.00M
est: 449.17M (+17.8%)
|
517.00M
est: 477.12M (+8.4%)
|
510.00M
est: 524.58M (-2.8%)
|
105.63M
91.55M – 117.32M
-79.9% YoY
|
94.88M
90.26M – 99.50M
-10.2% YoY
|
93.20M
92.69M – 93.72M
-1.8% YoY
|
91.88M
90.26M – 93.51M
-1.4% YoY
|
97.62M
92.87M – 102.38M
+6.3% YoY
|
| EPS |
0.86
est: 0.98 (-12.4%)
|
0.95
est: 1.30 (-26.6%)
|
1.65
est: 1.62 (+1.7%)
|
1.43
est: 1.57 (-8.7%)
|
2.24
est: 1.77 (+26.9%)
|
1.66
est: 1.77 (-6.2%)
|
2.01
est: 2.03 (-0.9%)
|
1.55
est: 2.05 (-24.4%)
|
2.15
est: 2.22 (-3.3%)
|
1.33
est: 1.95 (-31.7%)
|
1.06
est: 1.74 (-39.0%)
|
-0.53
est: 2.10 (-125.2%)
|
1.42
est: 1.78 (-20.3%)
|
0.58
est: 1.46 (-60.2%)
|
2.12
est: 1.44 (+47.4%)
|
1.32
1.19 – 1.47
-8.5% YoY
|
1.54
1.41 – 1.74
+17.1% YoY
|
1.78
1.58 – 2.35
+15.6% YoY
|
2.29
2.14 – 2.43
+28.5% YoY
|
2.43
2.28 – 2.58
+6.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-18 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-05 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-01 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-15 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Liam Condon | Chief Executive Officer & Director | 3M | male |
| Alastair Judge | CFO & Executive Director | — | male |
| Alberto Giovanzana | Managing Director of Catalyst Technologies | — | male |
| Carol Frost | Chief Human Resource Officer | — | female |
| Eugene McKenna | Managing Director of Green Hydrogen Activities | — | male |
| Liz Rowsell | Chief Technology Officer | — | female |
| R. Mannion | Managing Director of Ammonia, Menthol & Gas - Environmental Technologies | — | — |
| Richard Neil Pike AMCT ATII | COO & Executive Director | — | male |
| A. C. Hurst | Managing Director of Tracerco - Environmental Technologies | — | — |
| Simon Price | Company Secretary & General Counsel | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for JMAT.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
